
Pharmacy contract draws apathy not anger, columnist argues
A Chemist+Druggist opinion piece published on 10 June 2026 captures a mood that may be harder to shake than outright opposition. Writing under the name Xrayser, the columnist describes the sector's response to the new pharmacy contract in blunt terms: "There's apathy about the new contract, it's just meh..."
What happened
Xrayser's piece, published in Chemist+Druggist on 10 June 2026, sets out a case that the pharmacy workforce has moved past frustration with contracting decisions and settled into something closer to disengagement. The headline quote sums it up: not fury, not campaigning energy — just a flat, deflated shrug.
Why it matters
Apathy is a different problem to anger. Angry people write to MPs, show up at meetings, and vote in consultation exercises. Disengaged people don't. If Xrayser's read of the mood is right, then the people who might push for better terms are simply too worn down to bother.
For anyone entering the profession now, that context shapes the working environment you're heading into. The contract sets the financial and operational frame for community pharmacy — what services get commissioned, what they pay, and whether a pharmacy can sustain the staff levels that make clinical work possible. A workforce that's stopped fighting those terms isn't necessarily at peace with them.
The piece doesn't describe a profession that's given up on patients. It describes one that's given up on expecting the system to value what it does — and those aren't the same thing. That distinction matters for anyone thinking about where community pharmacy sits in the NHS and what its long-term place might look like.
What's next
Watch for how representative bodies respond to this kind of published sentiment. Opinion columns don't set policy, but they do reflect and amplify what people are saying privately. If apathy is genuinely widespread, the case for a better-funded contract becomes harder to make at the negotiating table — not easier.
For pre-registration trainees, it's worth reading primary sources like Chemist+Druggist regularly. The tone of professional commentary tells you things about the sector that policy documents don't.
Source: Chemist+Druggist — https://www.chemistanddruggist.co.uk/analysis/opinion/xrayser-theres-apathy-about-the-new-contract-its-just-meh-OLOVFRCJYZCELBOL2EG6PBJLIA/